spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Nuvelo 

 HSMN NewsFeed - 18 May 2018
Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Apr 2014
Coherus Biosciences Appoints Michael A. Fleming as Senior Vice President, Commercial Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2013
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Diagnostics Personnel
 HSMN NewsFeed - 17 Dec 2009
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2008
Medivation Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2008
Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2007
Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
Biopharmaceuticals Neurology Interventional
 HSMN NewsFeed - 30 Aug 2007
Hana Biosciences Appoints S. Michael Imperiale, Jr., M.D., as Vice President, Clinical Research Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Aug 2007
Hana Biosciences Appoints Dr. Steven R. Deitcher President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Aug 2007
Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2007
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2007
Archemix and Merck KGaA Sign Strategic Alliance
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2007
Hana Biosciences Announces Appointment of Steven R. Deitcher, M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2007
Nuvelo Receives FDA Fast Track Status for rNAPc2 in Both First- and Second-Line Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Jan 2007
Aerovance Names Mark L. Perry President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2006
Nuvelo and Bayer Healthcare Announce Phase 3 Trials of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion and Catheter Occlusion Did Not Meet Primary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2006
Nuvelo Announces Presentations on Alfimeprase and rNAPc2 at The American Heart Association Scientific Sessions 2006
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Sep 2006
Nuvelo Announces Completion of Patient Enrollment in SONOMA-2, First Phase 3 Trial of Alfimeprase in Central Venous Catheter Occlusion
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2006
Nuvelo Announces Completion of Patient Enrollment in NAPA-2, First Phase 3 Trial of Alfimeprase in Acute Peripheral Arterial Occlusion
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2006
Kosan Appoints Gary Titus Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2006
Nuvelo Appoints H. Ward Wolff as Chief Financial Officer and Jill M. Pergande as Vice President, Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2006
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2006
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2006
Nuvelo Announces Completion of Phase 2 Heparin Replacement Trial Evaluating rNAPc2 in Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Mar 2006
Nuvelo Appoints Shelly D. Guyer Vice President, Business Development and Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2006
Nuvelo and Bayer HealthCare Begin SONOMA-3, Second Phase 3 Trial of Alfimeprase in Patients With Central Venous Catheter Occlusion
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2006
Nuvelo Receives FDA Fast Track Status for Alfimeprase
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jan 2006
Nuvelo and Bayer HealthCare Enter Comprehensive Collaboration Agreement to Maximize Global Development and Commercialization of Alfimeprase
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 24 additional stories matching:
Nuvelo
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.